Dispersion-engineered psyllium granules with resistant maltodextrin
A novel approach to psyllium granules designed to delay early viscosity buildup using resistant maltodextrin, enhancing drinkability and maintaining physiological benefits. Scalable technology allows for uniform dispersion, preventing rapid gelation.
Overview
Dispersion-engineered psyllium granules with resistant maltodextrin offer an innovative solution to the challenge of early viscosity buildup in psyllium-based products. By incorporating resistant maltodextrin, these granules ensure a uniform dispersion of psyllium particles, significantly reducing the occurrence of localized mucilage hotspots that lead to rapid gelation. This technology enhances drinkability without compromising the core physiological benefits of psyllium, such as gastrointestinal functionality and hydration.
Technical specifications
- Scalable Technologies: Uses spray drying and agglomeration methods to co-process psyllium and resistant maltodextrin.
- Material Composition: Utilizes food-grade, neutral materials that do not chemically alter psyllium fibers.
- Enhanced Dispersion: Resistant maltodextrin acts as a carrier to prevent early particle bridging, allowing for extended drinkability.
- Hydration Control: Delays the onset of viscosity by controlling early hydration dynamics, ensuring eventual swelling and hydration.
Technology readiness level
Currently at TRL 3, this technology has been validated in laboratory settings with initial phases of development focusing on characterization and optimization of the granules. Future phases will focus on comprehensive evaluation, including manufacturability and compatibility with various supplement formats.
About UNSW Sydney
UNSW Sydney is a comprehensive, multi‑faculty public research university spanning STEM, medicine, business and law, and the arts and social sciences. Industry connection is built into the model through a long‑running co‑op program and co‑location with a major hospital precinct in Randwick, enabling faster translation and trials. A Canberra campus deepens defence‑aligned collaboration. Research is supported by competitive awards from the Australian Research Council and the National Health and Medical Research Council, plus state programs and industry partnerships. A dedicated technology transfer office and founder programs guide IP, licensing, and startup formation with clear pathways for sponsored research.
delivered to your inbox.